NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MRNA

Moderna Inc

Apr 17 • 04:00PM ET

24.72

Dollar change -0.48
Percentage change -1.89	%

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB IVV VO SPY RSP XBI VBR XLV

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-9.28	Insider Own	11.45%	Shs Outstand	386.00M	Perf Week	0.88%
Market Cap	9.54B	Forward P/E	-	EPS next Y	-7.94	Insider Trans	0.43%	Shs Float	341.66M	Perf Month	-25.83%
Income	-3561.00M	PEG	-	EPS next Q	-3.11	Inst Own	71.06%	Short Float	14.58%	Perf Quarter	-26.79%
Sales	3.24B	P/S	2.95	EPS this Y	-10.54%	Inst Trans	7.34%	Short Ratio	4.38	Perf Half Y	-56.87%
Book/sh	28.24	P/B	0.88	EPS next Y	22.60%	ROA	-21.87%	Short Interest	49.80M	Perf Year	-76.19%
Cash/sh	18.21	P/C	1.36	EPS next 5Y	13.39%	ROE	-28.77%	52W Range	23.15 - 170.47	Perf YTD	-40.56%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-42.94%	ROI	-30.67%	52W High	-85.50%	Beta	1.99
Dividend TTM	-	Quick Ratio	3.62	Sales past 5Y	662.63%	Gross Margin	48.92%	52W Low	6.76%	ATR (14)	2.13
Dividend Ex-Date	-	Current Ratio	3.67	EPS Y/Y TTM	25.00%	Oper. Margin	-121.91%	RSI (14)	36.68	Volatility	5.31% 7.32%
Employees	5800	Debt/Eq	0.07	Sales Y/Y TTM	-52.75%	Profit Margin	-110.04%	Recom	2.89	Target Price	48.95
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-629.50%	Payout	-	Rel Volume	0.59	Prev Close	25.19
Sales Surprise	2.46%	EPS Surprise	-8.57%	Sales Q/Q	-65.54%	Earnings	May 01 BMO	Avg Volume	11.37M	Price	24.72
SMA20	-11.74%	SMA50	-20.88%	SMA200	-56.20%	Trades		Volume	6,675,218	Change	-1.89%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Today 03:31PM	US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years (Benzinga)
10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
09:20AM	GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 (Zacks)
Apr-14-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-11-25 11:33AM	NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab (Zacks) +6.94%
11:20AM	Loading…
11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
08:39AM	Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer (Seeking Alpha)
Apr-10-25 12:01PM	Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. (Investor's Business Daily) -8.14%
07:00AM	Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 (ACCESSWIRE)
Apr-08-25 07:25PM	Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022 (Motley Fool) +8.24%
02:09PM	Is Moderna, Inc. (MRNA) the Best Long Term Growth Stock to Buy According to Billionaires? (Insider Monkey)
06:55AM	VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe (Zacks)
Apr-07-25 07:00AM	Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025 (ACCESSWIRE)
Apr-05-25 06:34PM	Jim Cramer Calls Moderna (MRNA) 'Problematic' (Insider Monkey)
Apr-04-25 08:15AM	Is Moderna Stock A Sell After Massive Job Cuts Wrack U.S. Health Agencies? (Investor's Business Daily)
01:00AM	Loading…
01:00AM	11 Stocks to Buy After the Biotech Bloodbath (Barrons.com)
Apr-03-25 09:05PM	Analyst Report: Moderna, Inc. (Morningstar Research) -7.18%
03:39PM	FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS (Yahoo Finance)
08:30AM	Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna (Motley Fool)
06:20AM	Is Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) a Strong ETF Right Now? (Zacks)
04:08AM	FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? (Motley Fool)
Apr-02-25 12:43PM	Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump (TipRanks)
07:37AM	PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo (Zacks)
Apr-01-25 12:42PM	Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
12:15PM	3 Market Predictions For April (Seeking Alpha)
11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks)
08:00AM	Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease (PR Newswire)
07:45AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:23AM	Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. (Zacks)
Mar-31-25 10:29PM	Watch These Moderna Price Levels as Stock Sinks to 5-Year Low (Investopedia) -8.90%
05:15PM	Loading…
05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha)
04:40PM	S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official (Investopedia)
04:13PM	Moderna (MRNA) Stock Trades Down, Here Is Why (StockStory)
04:12PM	Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies' (Investor's Business Daily)
01:58PM	Why Moderna Stock Is Plummeting Today (Motley Fool)
01:07PM	Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says wishes subservient confirmation of his misinformation and lies (Fortune)
12:26PM	Moderna, Rocket, Hut 8: Market Minute (Yahoo Finance Video)
12:01PM	Top Stock Movers Now: Tesla, Nvidia, Moderna, and More (Investopedia)
11:52AM	Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' (Investopedia)
11:10AM	Stocks to Watch Monday: Mr. Cooper, Nvidia, Newsmax, Moderna (The Wall Street Journal)
10:39AM	Moderna and other vaccines stocks are down after the FDA's top vaccine official resigns (Quartz)
09:57AM	Moderna, biotech stocks slide on resignation of FDA official Peter Marks (Yahoo Finance)
09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance)
09:45AM	Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns (Investor's Business Daily)
09:44AM	Moderna shares drop amid FDA leadership change (Yahoo Finance Video)
09:40AM	Stocks to Watch Monday: Nvidia, Tesla, Moderna, Robinhood (The Wall Street Journal)
09:31AM	Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out (The Wall Street Journal)
07:00AM	Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults (ACCESSWIRE)
Mar-29-25 04:17PM	Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year's Biggest Disappointments (Insider Monkey)
Mar-28-25 04:00PM	China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market (Investor's Business Daily) -8.90%
09:48AM	Arbutus Biopharma: A Wing And A Prayer (Seeking Alpha)
Mar-27-25 01:13PM	Jim Cramer: Moderna (MRNA) Blew It - But Their Cash Pile Could Save Them! (InsiderMonkey)
12:55PM	Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull? (Investor's Business Daily)
11:30AM	U.S. to end funding for child vaccines in developing countries, NY Times reports (TipRanks)
10:27AM	Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears (InsiderMonkey)
Mar-26-25 04:58PM	S&P 500 Gains and Losses Today: Supermicro, Arista Networks, and Nvidia Lead Tech Selloff (Investopedia) -7.00%
03:45PM	As Vaccine Skepticism Mounts, Modernas Business Grows More Precarious (Barrons.com)
09:20AM	Allspring Global Long/Short Equity Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 05:39PM	Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts (InsiderMonkey)
08:00AM	Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform (Business Wire)
Mar-24-25 09:32AM	Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025 (InsiderMonkey)
05:01AM	Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks (StockStory)
Mar-22-25 09:37AM	Moderna price target lowered to $33 from $40 at JPMorgan (TipRanks)
06:44AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
03:20AM	BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections (SeekingAlpha)
Mar-21-25 04:43PM	Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-20-25 05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
02:11PM	U.S. boosts bird flu response with another $100M in funds (SeekingAlpha)
08:45AM	4 Things You Need to Know if You Buy Moderna Stock Today (Motley Fool)
Mar-19-25 06:10PM	2 No-Brainer Biotech Stocks to Buy Right Now (Fool)
10:11AM	Merck Loses Almost $52B in 6 Months: How to Play MRK Stock (Zacks)
05:05AM	A Look Back at Therapeutics Stocks Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack (StockStory)
04:00AM	Vaccine makers face mRNA backlash as states seek further restrictions (Pharma Voice)
Mar-17-25 05:50PM	Moderna (MRNA) Advances But Underperforms Market: Key Facts (Zacks)
Mar-15-25 07:00AM	MarketBeat Week in Review - 03/10 - 03/14 (MarketBeat)
04:38AM	Down 93%, Is It Finally Time to Buy Moderna? (Motley Fool)
Mar-14-25 01:36PM	Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last? (GuruFocus.com)
Mar-13-25 11:34AM	Citi says SMid biotechs alternative to large caps as it starts coverage (Investing.com)
Mar-12-25 05:05AM	3 Reasons MRNA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-11-25 05:03AM	Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks (StockStory) -6.12%
Mar-09-25 03:00AM	3 CEOs Just Spent Millions Buying Their Beaten-Down Stock (Barrons.com)
Mar-08-25 11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
Mar-07-25 04:04PM	Why Moderna Stock Has Surged 15% This Week Despite Mixed News (Investor's Business Daily)
Mar-06-25 07:55AM	Why Moderna, Inc. (MRNA) Went Up on Wednesday (Insider Monkey)
Mar-05-25 05:59PM	Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday (Motley Fool) +15.94%
04:47PM	S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism (Investopedia)
04:00PM	The Dow surges 500 points as Trump hands out some tariff relief (Quartz)
01:06PM	Why Moderna (MRNA) Stock Is Rallying Today (Insider Monkey)
01:05PM	Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute (GuruFocus.com)
12:19PM	Moderna, Alibaba & Tencent, BlackRock: Market Minute (Yahoo Finance Video)
10:02AM	German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent (Reuters)
09:35AM	Moderna Stock Is Surging. The CEO Bought $5 Million of Shares. (Barrons.com)
Mar-04-25 04:10AM	Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80% (Motley Fool)
04:03AM	Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4 (StockStory)
Mar-01-25 10:35AM	Moderna receives MHRA marketing authorization for RSV vaccine (TipRanks)
Feb-28-25 10:30AM	Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine (ACCESSWIRE)
08:02AM	1 Healthcare Stock to Own for Decades and 2 to Ignore (StockStory)
03:15AM	3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. (Motley Fool)
Feb-27-25 04:37PM	Moderna Stock Slumps 7% On A Surprise Twist In The RFK Jr. Saga (Investor's Business Daily) -7.42%
04:29PM	These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience